Rare
lephants
Screener
Toggle theme
Kamada Ltd.
KMDA
·
Healthcare, Drug Manufacturers - General, Israel
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2020
FY2019
FY2018
FY2017
FY2016
Total Cash from Operations:
$22.7M
Line Item
Value
% of Total
Capital Expenditures
$4.2M
18.4%
Other Investing
$11.4M
50.4%
Working Capital
$3.8M
16.6%
Other
$607.0K
2.7%
Net Cash Flow
$2.7M
11.9%
Download CSV
